Health Care
Companies operating within the Health Care industry, ranked by market capitalization.
| Ticker | Exchange | Company Name | Last Price | % Change | Volume | Market Cap |
|---|---|---|---|---|---|---|
| XLO | NASDAQ | Xilio Therapeutics | $7.92 | +1.67% | 32K | $29.21M |
| IGC | NYSE MKT LLC | IGC Pharma | $0.32 | +3.16% | 715K | $28.77M |
| RADX | ASX - ALL MARKETS | Radiopharm Theranostics | $4.27 | -1.84% | 20K | $28.72M |
| TVRD | NASDAQ | Cara Therapeutics | $3.15 | +2.94% | 31K | $28.71M |
| SKYE | NASDAQ | Skye Bioscience | $0.88 | -1.71% | 320K | $28.66M |
| KYNB | NASDAQ | Kyntra Bio | $7.27 | +3.12% | 6K | $28.52M |
| LSTA | NASDAQ | Lisata Therapeutics | $3.12 | -3.11% | 55K | $28.4M |
| CCEL | NYSE MKT LLC | CryoCell International | $3.42 | -2.84% | 18K | $28.35M |
| AVCN.TO | TSX | Avicanna Inc | $0.15 | -3.33% | 214K | $27.97M |
| NEUP | NASDAQ | Neuphoria Therapeutics | $5.27 | +1.54% | 32K | $27.91M |
| ADK.V | TSXV | Diagnos Inc | $0.24 | -2.08% | 188K | $27.5M |
| DYAI | NASDAQ | Dyadic International DE | $0.78 | +3.54% | 97K | $27.42M |
| HBIO | NASDAQ | Harvard Bioscience | $6.38 | +4.08% | 24K | $27.33M |
| EUDA | NASDAQ | Euda Health Holdings | $14.53 | +0.28% | 1M | $26.92M |
| EVAX | NASDAQ | Evaxion Biotech A/S | $4.41 | +3.52% | 30K | $26.91M |
| AIFF | NASDAQ | WaveDancer | $2.24 | +13.13% | 813K | $26.7M |
| SONX | OTC | Sonendo | $0.50 | +51.52% | 64 | $26.35M |
| CLCS | OTC | Cell Source | $0.82 | +7.00% | 3K | $26.13M |
| SNTI | NASDAQ | Senti Biosciences | $0.92 | -5.99% | 207K | $25.86M |
| AYTU | NASDAQ | Aytu BioPharma | $2.58 | +2.38% | 19K | $25.67M |
| RYOJ | NASDAQ | rYojbaba Co. | $3.38 | +48.25% | 7K | $25.65M |
| CELU | NASDAQ | Celularity | $0.93 | -2.68% | 57K | $25.62M |
| TVGN | NASDAQ | Tevogen Bio Holdings | $6.64 | +3.43% | 15K | $25.51M |
| ABVC | NASDAQ | ABVC BioPharma | $1.03 | 0.00% | 57K | $25.03M |
| JSPR | NASDAQ | Jasper Therapeutics | $0.94 | +5.13% | 301K | $24.91M |
| BRNS | NASDAQ | Barinthus Biotherapeutics Plc. | $0.65 | +8.35% | 14K | $24.49M |
| CVM | NYSE MKT LLC | CelSci | $3.07 | +5.50% | 72K | $24.47M |
| VPT.V | TSXV | VentriPoint Diagnostics Ltd | $0.13 | +4.17% | 104K | $24.46M |
| RENB | NASDAQ | $0.00 | 0.00% | 896K | $24.44M | |
| TXMD | NASDAQ | TherapeuticsMD | $2.04 | -3.32% | 17K | $24.42M |
| MLSS | NYSE MKT LLC | Milestone Scientific | $0.31 | 0.00% | 486K | $24.37M |
| ASG.V | TSXV | Aurora Spine Corp | $0.28 | +1.82% | 85K | $24.32M |
| MRKR | NASDAQ | Marker Therapeutics | $1.46 | +0.69% | 85K | $24.18M |
| CXXI.CN | CSE | C21 Investments Inc | $0.44 | +12.82% | 145K | $24.01M |
| PMN | NASDAQ | ProMIS Neurosciences | $11.04 | -0.99% | 33K | $24M |
| NXTC | NASDAQ | Nextcure | $9.21 | +3.02% | 64K | $23.96M |
| APUS | NYSE MKT LLC | Apimeds Pharmaceuticals US | $1.88 | +7.43% | 0 | $23.64M |
| VTGN | NASDAQ | VistaGen Therapeutics | $0.61 | +2.94% | 492K | $23.54M |
| PLSM | TEL AVIV STOCK EXCHANGE | Pulsenmore | $3.39 | -4.51% | 6K | $23.09M |
| NSRX | – | Nasus Pharma | $2.70 | +5.47% | 168K | $23.07M |
| BTAI | NASDAQ | BioXcel Therapeutics | $1.23 | +18.27% | 601K | $22.74M |
| NWBO | OTC | Northwest Biotherapeutics | $0.20 | -0.33% | 5M | $22.66M |
| MENS | NASDAQ | Jyong Biotech | $2.27 | +4.13% | 57K | $22.35M |
| ADGM | NASDAQ | Adagio Medical Holdings | $0.90 | -14.26% | 264K | $22.24M |
| PIRS | – | Pieris Pharmaceuticals | $0.00 | 0.00% | NaN | $22.22M |
| LTRN | NASDAQ | Lantern Pharma | $2.05 | +3.54% | 241K | $22.15M |
| NNVC | NYSE MKT LLC | NanoViricides | $1.24 | +1.64% | 236K | $21.96M |
| ALLR | NASDAQ | Allarity Therapeutics | $1.35 | -2.17% | 109K | $21.82M |
| FEMY | NASDAQ | Femasys | $0.37 | -2.06% | 323K | $21.81M |
| QNTM | CSE | FSD Pharma Class B (Sub Voting) | $5.73 | +1.42% | 791K | $21.56M |